Having demonstrated that miR-671-5p inhibits EMT, which is implicated in the development of BC therapeutic resistance [26], we next addressed whether miR-671-5p reverses therapeutic resistance by inhibiting FOXM1-mediated EMT and/or DNA repair function. The gene discussed is FOXM1; the disease is breast cancer.